Categories: Latest News

NAFDAC approves R21 malaria vaccine

The National Agency for Food and Drug Administration and Control (NAFDAC) has granted registration approval for the R21 Malaria Vaccine (Recombinant, Adjuvanted) manufactured by Serum Institute of India Pvt. Ltd. (SIIPL).

The Director General of NAFDAC, Pro. Mojisola Adeyeye in a press briefing on Monday said the approval is made by the Agency in exercising its mandate as stipulated by its enabling law, NAFDAC Act CapN1, LFN 2004 adding that the Marketing Authorization Holder’s (MAHs) is Fidson Healthcare Ltd in line with the Agency’s Drug and Related Products Registration Regulation 2021.

Adeyeye explained that the R21 Malaria vaccine is an Adjuvanted protein vaccine presented as a sterile solution.

“A dose which is 0.5ml is composed of R21 Malaria antigen 5µg and Matrix-M1 50µg as an adjuvant filled in a vial as a ready-to-use liquid formulation for intramuscular injection.

“The vaccine is indicated for the prevention of clinical malaria in children from 5 months to 36 months of age. The storage temperature of the vaccine is 2-8 °C.”

While speaking further, Adeyeye said NAFDAC has several pathways for the registration of vaccines and these pathways are in line with the Agency’s guideline for registration of imported drugs, vaccines and IVDs under collaborative registration procedure, or the Agency’s guideline for registration of imported drug and vaccines.

“The R21 Malaria vaccine was reviewed using the latter which involves a full review of product dossiers.”

On dossier review, the DG said, NAFDAC received the dossier of the R21 Malaria manufactured by the Serum Institute of India Pvt Ltd (SSPL) and was subjected to independent review at two levels.

“As a matured regulatory agency, it is expected as part of global benchmarking that an external advisory committee is in place to advise upon invitation on certain functions of the Agency.

“As a new biological molecule that is being given consideration for full registration, the independent review by an external body becomes imperative as a means to further safeguard public health.”

 

 

READ ALSO FROM NIGERIAN TRIBUNE 

 

Kazeem Biriowo

Recent Posts

Defection hits Cross Rivers PDP as ex-guber candidate, others dump party

She clarified that her switch was not driven by personal gain or the pursuit of…

24 minutes ago

Give us 90-day extension to release Tinubu’s records — FBI, DEA appeal to US District Court

Greenspan is demanding the release of records linked to a Chicago drug ring and has…

30 minutes ago

Gombe: Police arrest ‘war contractor’, recover local rifle, ammunition

"And, he was found in unlawful possession of a locally fabricated automatic rifle, eight live…

42 minutes ago

CBN posts N165bn surplus in 2024 financial year

The Central Bank of Nigeria (CBN) has announced that its bottom-line improved from a deficit…

58 minutes ago

Olojudo’s coronation: Planning committee unveils programme of activities

Okunade while providing more clarification on the event, said, “This historic and culturally significant occasion…

1 hour ago

2025: Top 10 African countries with the largest oil reserves

Oil is one of the main drivers of economic growth in Africa. It fosters international…

2 hours ago

Welcome

Install

This website uses cookies.